☰

Kristi D. Viles, Ph.D. - Publications

Affiliations: 
2006 Duke University, Durham, NC 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Ray P, Viles KD, Soule EE, Woodruff RS. Application of aptamers for targeted therapeutics. Archivum Immunologiae Et Therapiae Experimentalis. 61: 255-71. PMID 23563807 DOI: 10.1007/S00005-013-0227-0  0.504
2013 Lawal NO, Viles KD, Barbas A, White RR. Gene and MicroRNA Profiling of Radioresistant Pancreatic Cancer Cell Lines Journal of Surgical Research. 179: 193. DOI: 10.1016/J.Jss.2012.10.216  0.38
2012 Rialon K, Viles K, Barbas A, Sullenger B, White R. In Vivo Selection of Aptamers Targeting Pancreatic Cancer Journal of Surgical Research. 172: 341. DOI: 10.1016/J.Jss.2011.11.709  0.62
2011 Barbas A, Viles K, Rialon K, Mi J, Clary B, Sullenger B, White R. In-vivo SELEX Against Pancreatic Cancer Xenografts Journal of Surgical Research. 165: 307. DOI: 10.1016/J.Jss.2010.11.362  0.599
2009 White R, Singh S, Hsu S, Viles K, Potti A, Nevins J, Ali-Osman F. 54: Development of a Gene Expression Profile for Predicting Gemcitabine Response in Pancreatic Cancer Journal of Surgical Research. 151: 195. DOI: 10.1016/J.Jss.2008.11.064  0.357
2008 White RR, Roy JA, Viles KD, Sullenger BA, Kontos CD. A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function. Angiogenesis. 11: 395-401. PMID 19037734 DOI: 10.1007/S10456-008-9122-4  0.581
2008 Viles KD, Sullenger BA. Proximity-dependent and proximity-independent trans-splicing in mammalian cells. Rna (New York, N.Y.). 14: 1081-94. PMID 18441053 DOI: 10.1261/Rna.384808  0.579
2008 Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 66-73. PMID 17912235 DOI: 10.1038/Sj.Mt.6300320  0.609
2006 McNamara JO, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology. 24: 1005-15. PMID 16823371 DOI: 10.1038/Nbt1223  0.638
Show low-probability matches.